The health benefit giant's fundamentals are good, but there are more symptoms to consider for a proper examination.
Warren Buffett's big bet on kidney dialysis provider DaVita may finally be primed to start paying off, albeit after five frustrating years of negative returns.
A low-risk countertrend options trade may be worth a look in this name.
Healthcare giants Johnson & Johnson and Pfizer offer a tough choice for dividend investors seeking the best returns.
The contagion in pharmacy stocks is spreading and secular trends aren't helping to find a solution anytime soon.
Might this be the bottom? It might.
Walgreens weak guidance is sending shares plummeting on Tuesday.
There's been enough news with the lawsuits around this name to get the emotion back into the stock. Emotion often leads to volatility.
It becomes difficult to own for anything other than a trade, managed care stocks and those that most benefit from Medicare expansion.
A health and wellness provider and an amusement park operator have seen insider purchases amid declines in their shares.